Previous close | 52.57 |
Open | 52.53 |
Bid | 47.18 x 100 |
Ask | 47.52 x 100 |
Day's range | 47.07 - 52.60 |
52-week range | 16.96 - 77.55 |
Volume | |
Avg. volume | 408,274 |
Market cap | 1.301B |
Beta (5Y monthly) | 1.25 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.07 |
Earnings date | 06 May 2024 - 10 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 60.33 |
NEW YORK, April 17, 2024--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in The Aesthetic Meeting 2024, which is being held May 2-5 in Vancouver, BC Canada.
Shareholders of Establishment Labs Holdings Inc. ( NASDAQ:ESTA ) will be pleased this week, given that the stock price...
Establishment Labs Holdings Inc. (NASDAQ:ESTA) Q4 2023 Earnings Call Transcript February 28, 2024 Establishment Labs Holdings Inc. beats earnings expectations. Reported EPS is $-0.79, expectations were $-0.95. ESTA isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. Welcome to […]